Dover has entered right into a definitive settlement to accumulate Malema Engineering Corp, a US designer and producer of high-precision, mission-critical flow-measurement and control devices for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s products will increase Dover’s biopharma single-use production offering, which already consists of Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in income during the full year 2022.
When the deal closes, Malema will turn into part of the PSG business unit within Dover’s Pumps & Process Solutions segment.
“We see an incredible long-term progress opportunity in the bioprocessing trade driven by a powerful and growing pipeline of effective novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, as nicely as budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more environment friendly single-use manufacturing processes helps a sturdy outlook for our offerings of single-use components to end-customers. We consider that pairing Malema’s expertise with our existing portfolio of single-use pumps for biopharma processing will greatly enhance the accuracy and value proposition of our solutions to our clients.”
“We are methodically constructing out our biopharma platform through proactive capacity additions, new product development, and opportunistic acquisitions of highly-attractive area of interest element applied sciences,” stated Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing know-how and additional strengthens our sensor portfolio with new proprietary know-how. In pressure gauge to enticing biopharma applications, we expect strong development in the semiconductor space on the capacity expansion and re-shoring tailwinds.”
Share